Skip to content

CAPRICOR THERAPEUTICS, INC.: 10-Q filed 2014-05-15

What CAPRICOR THERAPEUTICS, INC. reported in its quarterly report filed 2014-05-15 (fiscal Q1 2014): 27 published measures, 88 facts as tagged in accession 0001144204-14-031429.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-15
Fiscal period
fiscal Q1 2014
Accession
0001144204-14-031429 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CAPRICOR THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-3115,976,704USD
At 2013-12-315,537,907USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-03-3117,636,144USD
At 2013-12-316,072,789USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-31-1,659,440USD
At 2013-12-31-534,882USD
At 2012-12-314,894,423USD
At 2011-12-311,655,152USD
At 2010-12-311,788,974USD
At 2009-12-31911,771USD
At 2008-12-31252,552USD
At 2007-12-31863,168USD
At 2006-12-311,836,495USD
At 2005-12-310USD
At 2005-07-040USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-03-3112,979,150USD
At 2013-12-311,729,537USD
At 2013-03-31282,206USD
At 2012-12-31170,106USD
At 2005-07-040USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-1,210,611USD90
2005-07-05 to 2014-03-31-17,309,146USD3192
2013-01-01 to 2013-12-31-8,891,924USD365
2013-01-01 to 2013-03-31-1,417,114USD90
2012-01-01 to 2012-12-31-2,071,255USD366
2011-01-01 to 2011-12-31-1,149,320USD365
2010-01-01 to 2010-12-31-1,055,748USD365
2009-01-01 to 2009-12-31-148,970USD365
2008-01-01 to 2008-12-31-630,859USD366
2007-01-01 to 2007-12-31-979,076USD365
2006-01-01 to 2006-12-31-1,171,419USD365
2005-07-05 to 2005-12-3136USD180

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-03-3192,901USD90
2005-07-05 to 2014-03-31377,824USD3192
2013-01-01 to 2013-03-313,144USD90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,041,667USD90
2005-07-05 to 2014-03-315,222,637USD3192
2013-01-01 to 2013-03-31233,291USD90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-03-31163,539USD
At 2013-12-3174,187USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-03-3184,544USD90
2005-07-05 to 2014-03-31750,667USD3192
2013-01-01 to 2013-03-3141,373USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-1,185,437USD90
2005-07-05 to 2014-03-31-15,457,729USD3192
2013-01-01 to 2013-03-31-1,432,292USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-3114,030,944USD
At 2013-12-313,680,840USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-03-3125,327USD90
2005-07-05 to 2014-03-3183,461USD3192
2013-01-01 to 2013-03-313,711USD90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-316,299,284USD
At 2013-12-312,052,922USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-03-31228,382USD
At 2013-12-31227,207USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-03-312,227,104USD90
2005-07-05 to 2014-03-3120,680,366USD3192
2013-01-01 to 2013-03-311,665,583USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-03-311,374,757USD90
2005-07-05 to 2014-03-3112,874,352USD3192
2013-01-01 to 2013-03-311,191,154USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-3111,690,859shares
At 2013-12-3111,687,747shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-03-3115,638,420USD
At 2013-12-3115,552,946USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-03-31-404USD
At 2013-12-31-980USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-03-31247,517USD
At 2013-12-31154,616USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-03-3183,978USD
At 2013-12-3180,429USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-03-31169,579USD
At 2013-12-31222,763USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-03-31576USD90
2005-07-05 to 2014-03-31-404USD3192
2013-01-01 to 2013-03-31-8,763USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31852,347USD90
2005-07-05 to 2014-03-317,806,014USD3192
2013-01-01 to 2013-03-31474,429USD90

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-03-316,465USD90
2005-07-05 to 2014-03-31171,197USD3192
2013-01-01 to 2013-03-316,120USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-25,174USD90
2005-07-05 to 2014-03-31-1,851,417USD3192
2013-01-01 to 2013-03-3115,178USD90

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2014-01-01 to 2014-03-310USD90
2005-07-05 to 2014-03-310USD3192
2013-01-01 to 2013-03-310USD90

Inspect the source

Entity
CAPRICOR THERAPEUTICS, INC. / CIK 0001133869
Captured
2026-09-20T07:41:24.575Z
SEC response SHA-256
b9f947143784aa2a5b7cc0470638338f21bd5664475f1be49c554014f98dbf5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133869.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))